200 related articles for article (PubMed ID: 20308301)
1. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.
Stearns-Kurosawa DJ; Collins V; Freeman S; Tesh VL; Kurosawa S
Infect Immun; 2010 Jun; 78(6):2497-504. PubMed ID: 20308301
[TBL] [Abstract][Full Text] [Related]
2. Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.
Stearns-Kurosawa DJ; Oh SY; Cherla RP; Lee MS; Tesh VL; Papin J; Henderson J; Kurosawa S
Am J Pathol; 2013 Apr; 182(4):1227-38. PubMed ID: 23402998
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
[TBL] [Abstract][Full Text] [Related]
4. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
Jeong KI; Tzipori S; Sheoran AS
J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
[TBL] [Abstract][Full Text] [Related]
5. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.
Siegler RL; Obrig TG; Pysher TJ; Tesh VL; Denkers ND; Taylor FB
Pediatr Nephrol; 2003 Feb; 18(2):92-6. PubMed ID: 12579394
[TBL] [Abstract][Full Text] [Related]
6. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
Wen SX; Teel LD; Judge NA; O'Brien AD
Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
[TBL] [Abstract][Full Text] [Related]
7. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
8. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
[TBL] [Abstract][Full Text] [Related]
9. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
[TBL] [Abstract][Full Text] [Related]
10. Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.
Park JY; Jeong YJ; Park SK; Yoon SJ; Choi S; Jeong DG; Chung SW; Lee BJ; Kim JH; Tesh VL; Lee MS; Park YJ
Toxins (Basel); 2017 Oct; 9(10):. PubMed ID: 29027919
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.
Jandhyala DM; Ahluwalia A; Schimmel JJ; Rogers AB; Leong JM; Thorpe CM
Infect Immun; 2016 Jan; 84(1):138-48. PubMed ID: 26483408
[TBL] [Abstract][Full Text] [Related]
12. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.
Lentz EK; Leyva-Illades D; Lee MS; Cherla RP; Tesh VL
Infect Immun; 2011 Sep; 79(9):3527-40. PubMed ID: 21708996
[TBL] [Abstract][Full Text] [Related]
13. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli.
Vinh PT; Shinohara Y; Yamada A; Duc HM; Nakayama M; Ozawa T; Sato J; Masuda Y; Honjoh KI; Miyamoto T
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31470657
[TBL] [Abstract][Full Text] [Related]
14. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
[TBL] [Abstract][Full Text] [Related]
15. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
Li B; Liu H; Wang W
BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
[TBL] [Abstract][Full Text] [Related]
16. New high-affinity monoclonal antibodies against Shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 in vivo.
Skinner C; Patfield S; Stanker LH; Fratamico P; He X
PLoS One; 2014; 9(6):e99854. PubMed ID: 24914553
[TBL] [Abstract][Full Text] [Related]
17. Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathy.
Lee BC; Mayer CL; Leibowitz CS; Stearns-Kurosawa DJ; Kurosawa S
Blood; 2013 Aug; 122(5):803-6. PubMed ID: 23733336
[TBL] [Abstract][Full Text] [Related]
18. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
Basu D; Tumer NE
Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
[TBL] [Abstract][Full Text] [Related]
20. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a
Petro CD; Trojnar E; Sinclair J; Liu ZM; Smith M; O'Brien AD; Melton-Celsa A
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
